RBMS1 Depletion Sensitizes TNBC to PD-L1 Checkpoint Blockade
2026-06-29
The reference study reveals RBMS1 as a post-transcriptional regulator of PD-L1 in triple-negative breast cancer (TNBC). Loss of RBMS1 destabilizes PD-L1 via B4GALT1 mRNA, enhancing anti-tumor immunity and improving response to checkpoint blockade, suggesting new combinatorial immunotherapy strategies.
PKH26 Red Fluorescent Cell Linker Kit: Technical Protocol &
2026-06-29
The PKH26 Red Fluorescent Cell Linker Kit is designed for stable, membrane-specific fluorescent labeling to support cell tracing and proliferation detection in vitro and in vivo. It is not suitable for intracellular or non-membrane labeling applications, ensuring specificity for studies focused on cell membrane dynamics.
TRPA1 and TRPV1 Drive TSLP Release in Nasal Epithelial Cells
2026-06-28
This study establishes that TRPV1 and TRPA1 channels are functionally expressed in nasal epithelial cells and that their activation directly promotes TSLP secretion via a Ca2+/NFAT-dependent pathway. These findings clarify a mechanistic link between sensory ion channel signaling and airway inflammation, with implications for targeted research on nonallergic rhinitis and related conditions.
Bufalin: Cardiotonics Redefining Triple-Negative Breast Canc
2026-06-27
Bufalin, a potent cardiotonic steroid from APExBIO, is unlocking new precision strategies in triple-negative breast cancer (TNBC) research through selective protein degradation and apoptosis induction. This article translates the latest mechanistic insights and protocol advances into actionable workflows, enabling scientists to maximize the translational impact of Bufalin while avoiding common experimental pitfalls.
Polygodial as a TRPA1 Channel Activator: Mechanisms and Next
2026-06-26
Explore how Polygodial, a potent TRPA1 channel activator, advances membrane transporter signaling studies. This article delivers deep mechanistic insights and innovative assay strategies distinct from existing guides.
Polygodial as a Precision TRPA1 Channel Activator: Experimen
2026-06-26
Explore how Polygodial, a potent TRPA1 channel activator, advances sensory neuron and epithelial research through rigorous assay design and reproducibility. This article uniquely dissects experimental controls and reliability considerations for membrane transporter signaling studies.
740 Y-P: PI 3-Kinase Activator for Vesicular and Neuronal Re
2026-06-25
740 Y-P stands out as a potent, cell-permeable PI 3-kinase activator ideal for dissecting the PI3K/AKT pathway in vesicular trafficking and neuronal survival assays. Protocol flexibility and robust activation underpin its utility for troubleshooting complex apoptosis and cell stress models.
Octenidine Dihydrochloride: Mechanistic Insights and Researc
2026-06-25
Explore the molecular mechanism, solubility challenges, and optimal research applications of Octenidine dihydrochloride, an advanced antiseptic research compound. This article uniquely connects structure-activity relationships to practical assay design and laboratory workflows.
Bufuralol Hydrochloride: Precision β-Adrenergic Modulation i
2026-06-24
Bufuralol hydrochloride, a non-selective β-adrenergic receptor antagonist, is pivotal for advanced cardiovascular pharmacology research. This article uniquely explores its integration into human intestinal organoid-based pharmacokinetic assays, revealing novel insights beyond traditional models.
Degarelix Acetate in Prostate Cancer: Rapid Androgen Depriva
2026-06-23
The reference study demonstrates that degarelix acetate, a third-generation GnRH antagonist, enables rapid medical castration and prostate-specific antigen suppression in advanced prostate cancer, avoiding the testosterone surge seen with GnRH agonists. These findings inform both clinical treatment strategies and mechanistic research into androgen deprivation, with implications for translating hormonal modulation insights to other cancer models.
CUDC-907: Dual PI3K and HDAC Inhibition for Cancer Research
2026-06-23
CUDC-907 enables targeted dual inhibition of PI3K and HDAC pathways in established cancer cell models, supporting mechanistic studies of signaling, cell cycle arrest, and apoptosis. It is intended strictly for in vitro research in controlled laboratory workflows and is not suitable for diagnostic, therapeutic, or clinical applications.
CLCC1 Identified as Key Host Factor in Herpesvirus Nuclear E
2026-06-22
The reference study uncovers CLCC1 as an essential host mediator of membrane fusion during herpesvirus nuclear egress, resolving a long-standing gap in the understanding of HSV-1 replication. This mechanistic insight into viral-host interplay informs both fundamental virology and translational research in antiviral immunotherapy.
EZH2 Maintains Epithelial Identity in Breast Carcinoma Cells
2026-06-22
Gallardo et al. reveal that EZH2, the catalytic subunit of PRC2, represses mesenchymal gene expression to maintain the epithelial state in breast carcinoma cells. This finding clarifies a conserved mechanism of epigenetic regulation during epithelial-mesenchymal transitions in cancer, with implications for targeted inhibition strategies.
Azilsartan Medoxomil Monopotassium Outperforms in Hypertensi
2026-06-21
A comprehensive network meta-analysis demonstrates that azilsartan medoxomil (TAK 491) achieves superior systolic and diastolic blood pressure reductions compared to other antihypertensive agents in mild-to-moderate hypertension. The study's robust design and ranking methodology provide strong support for its use in essential hypertension treatment research and blood pressure regulation studies.
4-Hydroxytamoxifen: Technical Guidance for Cancer Research
2026-06-20
4-Hydroxytamoxifen is a high-purity estrogen receptor modulator designed for DMSO-based workflows in breast and prostate cancer research, as well as cardiac myocyte calcium handling studies. It should not be used in protocols requiring aqueous or ethanol solubility, and proper storage and preparation are essential for reproducibility.
466 records 14/32 page Previous Next First page 上5页 1112131415 下5页 Last page